Dan Crimmins

Title: Dan Crimmins: Innovator in Renal Injury Detection and Caffeine Analysis

Introduction

Dan Crimmins is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the fields of renal injury detection and caffeine analysis. With a total of 2 patents, his work has implications for both medical diagnostics and biochemical analysis.

Latest Patents

Crimmins' latest patents include the Miox antibody and assay, which relates to compositions and methods for detecting renal injury in a subject, particularly proximal tubular injury associated with acute kidney injury. Another significant invention is a method for determining and lowering caffeine concentration in fluids. This patent describes single-chain, camelized heavy chain antibodies that are immunospecific for caffeine and stable at high temperatures. These innovations are useful for the analysis and recovery of caffeine in or from fluids, including a device that provides a single-step lateral flow assay for caffeine.

Career Highlights

Dan Crimmins is affiliated with Washington University, where he continues to advance research in his areas of expertise. His work has garnered attention for its practical applications in healthcare and environmental monitoring.

Collaborations

Crimmins has collaborated with esteemed colleagues such as Jack H. Ladenson and Vijay Modur, contributing to a rich environment of innovation and research.

Conclusion

Dan Crimmins exemplifies the spirit of innovation through his patents and contributions to science. His work not only enhances our understanding of renal injuries but also improves methods for caffeine analysis.